![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Faldum Andreas Hommel Gerhard
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.17, Iss.6, 2007-11, pp. : 1211-1225
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Interim Analyses in Clinical Trials
Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Strategies to Measure and Improve Patient Adherence in Clinical Trials
Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ethical Issues in Including Pediatric Cancer Patients in Drug Development Trials
By Aleksa K.
Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. :